Actavis, Others Can't Yet Market Generic Nucynta, Judge Says
Actavis and two other drugmakers can't launch a generic version of Depomed Inc.'s painkiller Nucynta until the New Jersey federal judge who oversaw a patent infringement trial between the companies makes...To view the full article, register now.
Already a subscriber? Click here to view full article